Douglas E. Coltharp - 24 Feb 2022 Form 4 Insider Report for Encompass Health Corp (EHC)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: EHC
Reported as of: 24 Feb 2022
Net transaction value: -$45,733
SEC form: 4
Accepted by SEC: 28 Feb 2022, 12:44:41 UTC
Prior SEC filing: 23 Feb 2022
Next SEC filing: 02 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Douglas E. Coltharp

Key filing fact

Douglas E. Coltharp filed Form 4 for Encompass Health Corp (EHC) on 28 Feb 2022.

Key facts

This page summarizes Douglas E. Coltharp's Form 4 filing for Encompass Health Corp (EHC).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Feb 2022, 12:44.

Change

Previous filing in this sequence was filed on 23 Feb 2022.
Current net transaction value: -$45,733.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHC transaction

Encompass Health Common Stock

Tax liability

Transaction value: $45,733
Shares: -698
Change %: -1.8%
Price: $65.52
Shares after: 37,078
Date: 24 Feb 2022
Ownership: Direct
Footnotes: F1

EHC transaction

Encompass Health Common Stock

Award

Transaction value: $0
Shares: +6,054
Change %: +16%
Price: $0.000000
Shares after: 43,132
Date: 25 Feb 2022
Ownership: Direct
Footnotes: F2

EHC transaction

Encompass Health Common Stock

Award

Transaction value: $0
Shares: +11,816
Change %: +27%
Price: $0.000000
Shares after: 54,948
Date: 25 Feb 2022
Ownership: Direct
Footnotes: F3

EHC holding

Encompass Health Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 125,631
Date: 24 Feb 2022
Ownership: By irrevocable trust for the benefit of children

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Footnote F2

Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Footnote F3

This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020.